Amneal announces move to nasdaq

Bridgewater, n.j.--(business wire)--amneal pharmaceuticals, inc. (“amneal”) (nyse: amrx) today announced that it will transfer its stock exchange listing to the nasdaq stock market (“nasdaq”) from the new york stock exchange (“nyse”). the company expects the nasdaq listing to occur on december 27, 2023 and will continue to trade under the current symbol “amrx”. upon transferring, amneal will become part of the nasdaq composite index and nasdaq biotechnology index. “we are pleased to join the co.
AMRX Ratings Summary
AMRX Quant Ranking